First bispecific antibody approved in EU to combat leading causes of vision loss

Elderly Asian woman lifting glasses as she struggles to read text on her phone - idea of vision loss in the elderly such as through age-related macular degeneration

First bispecific antibody approved in EU to combat leading causes of vision loss

Roche’s Vabysmo^® (faricimab) has been approved in Europe as a four-monthly treatment for wet age-related macular degeneration and diabetic macular oedema.